Measurement of various biomarkers in healthy subjects

UMIN ID: UMIN000055278

Registered date:06/09/2024

Basic Information

• Recruitment status: Complete: follow-up complete
• Health condition(s) or Problem(s) studied: Adult
• Date of first enrollment: 2024/09/19
• Target sample size: 100
• Countries of recruitment: Japan
• Study type: Observational

Outcome(s)

• Primary Outcome: Telomere Length SIRT1mRNA Alpha-Klotho(water-soluble) 8-OHdG(urine) sIgA(Saliva)

Key inclusion & exclusion criteria

• Age minimum: 20years-old
• Age maximum: Not applicable
• Gender: Male and Female
• Exclude criteria: 1) Subjects with severe liver impairment, renal or heart disease, diabetes, or other serious illnesses. 2) Subjects who are receiving medication treatment or are scheduled to receive medication during the study period. 3) Subjects who have participated in other clinical trials or studies within 84 days prior to the date of consent. 4) Subjects who have donated 400 mL of blood within 84 days, 200 mL of blood within 28 days, or have undergone apheresis (plasma or platelet donation) within 14 days prior to the date of consent. 5) Pregnant or breastfeeding women, and those who wish to become pregnant during the study period. 6) Subjects who are deemed inappropriate for participation in this study by the principal investigator.

Related Information

• Primary Sponsor: Yamada Bee Company, Inc.
• Secondary Sponsor: Research Center for Immunological Analysis, Inc.
• Source(s) of Monetary Support: Yamada Bee Company, Inc.